The Motley Fool

The dividend stock set to soar 30%+ by the end of 2018

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Buying a turnaround stock can often be a profitable move. Certainly, there is a risk that its comeback will falter, but there is also the potential for high capital gains in the long run. Reporting on Thursday was a stock which has already returned to profitability and is now looking ahead to significant growth. As such, now could be the right time to buy it.

A transitional year

The company in question is RSA Insurance (LSE: RSA). Its results for last year show it has become a strong, organic growth play which is delivering much-improved levels of profitability. For example, group operating profit moved 25% higher, while its underwriting profit of £380m was a record level. It completed the disposals of its businesses in Latin America and Russia, which brings it a step closer to its principal disposal programme of achieving a more concentrated strategic focus.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

RSA’s balance sheet and capital ratios provide further evidence of its return to health. Its solvency II coverage ratio of 158% is at the upper end of its 130-160% target, while its reserve margin was strengthened by 50 basis points to 5.5% during the year. It should be relatively well-insulated from the effects of Brexit, since around 70% of its profit is derived from currencies other than sterling.


Profit growth of 51% is forecast for the current year, while further growth of 18% is expected next year. RSA could even gain a currency boost from weaker sterling during the two-year period, which would lead to an upgrade to its guidance.

However, even if this does not take place the company’s price-to-earnings growth (PEG) ratio of 0.7 indicates that there is significant upward rerating potential. Even if its shares were to rise by 30%, it would still be trading on a price-to-earnings (P/E) ratio of 16 by the end of next year. Given its potential for double-digit profit growth in the long run, this would not be a particularly demanding valuation. That’s especially the case since RSA is transitioning from a turnaround stock to one which has a sound financial base and a more attractive business model through which to report higher profitability.

This should positively impact on RSA’s dividends. It currently yields 3.4%, but with such strong growth potential and a dividend which is covered twice by profit, a significantly higher yield could be on offer in future years.

Sector Peer

Insurance sector peer Hiscox (LSE: HSX) trades on a P/E ratio of 16.6 at the present time. This is higher than RSA’s rating would be if its shares moved 30% higher and it meets its guidance over the next two years. Even on such a heady P/E ratio, Hiscox does not seem to be overvalued. It is due to report a rise in earnings of 10% in 2018, which puts it on a relatively attractive PEG ratio of 1.6. As such, it appears to be worth buying for the long term.

Hiscox has an excellent track record of growth, with profit rising in each of the last four years. As such, it may be viewed as somewhat lower risk than its sector peer. However, RSA is now a much stronger company than in recent years and seems to have the scope to rise by at least 30%, while offering a yield which is 0.8% higher than that of its sector peer.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.